\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\ and\\ laboratory\\:\\ \ \(0\)\
\-\ pertinent\\ physical\\ findings\\:\\ \\ abdomen\\-\\-distended\\,\\ non\\-tender\\,\\ ascites\\ present\\,\\ no\\ organomegaly\\ detected\\.\\ \\ exam\\ otherwise\\ benign\\.\ \(0\)\
\-\ lab\\ findings\\:\\ \\ chem7\\â\\€\\”141\\/5\\.0\\/105\\/31\\/12\\/0\\.6\\/112\\;\\ cbc\\â\\€\\”8\\.7\\/11\\.0\\/34\\.0\\/181\\;\\ coag\\ pt\\ 12\\.8\\/ptt\\ 27\\.8\\;\\ \ \(0\)\
\-\ lfts\\â\\€\\”alkphos\\ 1052\\/ast\\ 233\\/\\ alt\\ 91\\/\\ tbili\\ 2\\.7\\ \ \(0\)\
\-\ tumor\\ markers\\:\\ ca\\ 27\\-29\\ 1371\\ \\(normal\\ 0\\-37\\)\\,\\ ca\\ 15\\-3\\ 1464\\ \\(normal\\ 0\\-31\\)\\,\\ ca\\ 125\\ 196\\ \\(normal\\ 0\\-34\\)\\,\\ afp\\ normal\ \(0\)\
\-\ histology\\ of\\ breast\\ bx\\:\\ infiltrating\\ ductal\\ ca\\ t3n2m2\ \(0\)\
\-\ histology\\ of\\ liver\\ bx\\:\\ \\ adenocarcinoma\\;\\ special\\ stains\\ include\\ cytokeratin\\ 7\\:\\ positive\\,\\ cytokeratin\\ 20\\:\\ negative\\,\\ progesterone\\/estrogen\\:\\ positive\\,\\ cea\\:\\ focally\\ positive\\,\\ thyroid\\ transcription\\ factor\\ 1\\:\\ negative\\.\ \(0\)\
\-\ treatment\\ and\\ follow\\-up\\:\\ \ \(0\)\
\-\ plan\\ to\\ have\\ pt\\ follow\\-up\\ with\\ pulmonology\\ for\\ assessment\\ of\\ lung\\ function\\ and\\ work\\-up\\ of\\ lung\\ nodules\\.\\ \\ also\\,\\ pt\\ to\\ have\\ colonoscopy\\.\\ \\ consult\\ general\\ surgery\\ placed\\ for\\ evaluation\\ of\\ left\\ breast\\ mass\\.\\ this\\ patient\\ insisted\\ that\\ she\\ be\\ discharged\\ after\\ the\\ diagnostic\\ imaging\\ took\\ place\\ to\\ attend\\ an\\ important\\ family\\ event\\.\\ \\ thus\\,\\ she\\ was\\ discharged\\ on\\ hospital\\ day\\ six\\,\\ with\\ the\\ aforementioned\\ follow\\-up\\ appointments\\ made\\.\ \(0\)\
\-\ image\\ findings\\:\\ \ \(0\)\
\-\ 1\\.\\	pet\\ scan\\â\\€\\”2\\ hypermetabolic\\ foci\\ in\\ left\\ breast\\;\\ focal\\ hypermetabolic\\ uptake\\ in\\ inferior\\ right\\ liver\\ lobe\\ and\\ left\\ liver\\ lobe\\ with\\ diffuse\\/heterogeneous\\ uptake\\ in\\ right\\ lobe\\;\\ diffuse\\ bone\\ uptake\\ in\\ axial\\/appendicular\\ skeleton\\ that\\ is\\ nonspecific\\:\\ \\ malignant\\ vs\\ liver\\ failure\\.\ \(0\)\
\-\ 2\\.\\	mrcp\\/mri\\ abdomen\\â\\€\\”liver\\ cirrhosis\\ and\\ portal\\ htn\\ leading\\ to\\ splenomegaly\\ and\\ ascites\\;\\ no\\ pancreatic\\ ductal\\ dilatation\\;\\ liver\\ lesions\\ are\\ peripheral\\ with\\ capsular\\ retraction\ \(0\)\
\-\ 3\\.\\	ct\\ chest\\â\\€\\”too\\ numerous\\ to\\ count\\ non\\-calcified\\ nodules\\ in\\ lungs\\;\\ left\\ breast\\ lesion\\ and\\ axillary\\ lymph\\ node\ \(0\)\
\-\ 4\\.\\	breast\\ u\\/s\\ \\(image\\ not\\ available\\ for\\ medpix\\)\\ used\\ for\\ core\\ bx\\â\\€\\”1\\.2cm\\ lesion\\ in\\ left\\ upper\\ outer\\ breast\\;\\ birads\\ category\\ 5\ \(0\)\
\-\ diagnosis\\:\\ \\ 64\\ y\\.o\\.\\ female\\ with\\ recurrent\\ breast\\ cancer\\ with\\ metastasis\\ to\\ lymph\\ nodes\\ and\\ lungs\\.\\ \\ liver\\ mass\\ biopsy\\ reveals\\ adenocarcinoma\\,\\ with\\ histology\\ consistent\\ with\\ breast\\ tissue\\.\ \(0\)\
\-\ differential\\ diagnosis\\ for\\ these\\ findings\\ in\\ this\\ case\\:\ \(0\)\
\-\ 1\\.\\	liver\\ lesions\\ and\\ ascites\\:\\ \\ periportal\\ fibrosis\\,\\ cirrhosis\\ leading\\ to\\ hcc\\,\\ regenerating\\ nodules\\,\\ inflammation\\,\\ neoplastic\\ infiltration\\ in\\ interstitium\ \(0\)\
\-\ 2\\.\\	lung\\ nodules\\:\\ \\ metastasis\\,\\ infectious\\,\\ granulomatous\\,\\ tb\\,\\ mycobacterial\ \(0\)\
\-\ 3\\.\\	breast\\ lesions\\:\\ \\ primary\\ lesion\\,\\ metastasis\ \(0\)\
\-\ history\\ \\(can\\ include\\ gestational\\ age\\,\\ or\\ age\\ in\\ days\\,\\ weeks\\,\\ months\\)\\:\ \(0\)\
\-\ 64\\ y\\.o\\.\\ wf\\ with\\ hx\\ of\\ breast\\ ca\\ \\(1996\\)\\,\\ s\\/p\\ lumpectomy\\ and\\ xrt\\,\\ admitted\\ for\\ workup\\ of\\ fatigue\\,\\ 15\\-20\\ lb\\ weight\\ loss\\ in\\ 8\\ months\\,\\ and\\ increased\\ abdominal\\ girth\\ in\\ the\\ setting\\ of\\ imaging\\ studies\\,\\ which\\ show\\ ascites\\ \\(with\\ peritoneal\\ fluid\\ negative\\ for\\ malignant\\ cells\\)\\,\\ liver\\ lesions\\,\\ and\\ multiple\\ lung\\ masses\\.\\ \\ prior\\ workup\\ demonstrated\\ elevated\\ lfts\\,\\ elevated\\ cea\\,\\ ca\\ 19\\-9\\,\\ ca\\ 125\\,\\ and\\ negative\\ viral\\ hepatitis\\ panels\\.\ \(0\)\
\-\ discussion\\ \\(include\\ references\\)\\:\\ \ \(0\)\
\-\ the\\ lung\\ nodules\\ are\\ likely\\ adenocarcinoma\\,\\ which\\ is\\ the\\ most\\ common\\ type\\ of\\ lung\\ cancer\\ in\\ most\\ recently\\ reported\\ series\\,\\ and\\ is\\ the\\ most\\ frequent\\ histologic\\ type\\ in\\ women\\ and\\ nonsmokers\\ of\\ either\\ sex\\.\\ \\ \\ this\\ patient\\ has\\ a\\ 40\\ pack\\ year\\ hx\\ of\\ smoking\\.\\ \\ metastasis\\ is\\ the\\ most\\ common\\ neoplasm\\ in\\ an\\ adult\\ liver\\,\\ and\\ the\\ liver\\ is\\ the\\ second\\ most\\ common\\ site\\ for\\ metastatic\\ spread\\,\\ after\\ the\\ lymph\\ nodes\\.\\ \\ the\\ patient\\ also\\ has\\ recurrent\\ breast\\ cancer\\.\\ \\ infiltrating\\ ductal\\ carcinoma\\ is\\ the\\ most\\ common\\ type\\ of\\ invasive\\ breast\\ cancer\\,\\ accounting\\ for\\ 70\\ to\\ 80\\ percent\\ of\\ invasive\\ lesions\\.\\ \\ \\ the\\ final\\ pathology\\ report\\ indicates\\ that\\ the\\ liver\\ mass\\ is\\ adenocarcinoma\\,\\ with\\ the\\ special\\ stains\\ being\\ consistent\\ with\\ breast\\ tissue\\.\\ \\ the\\ ttf1\\ stain\\ is\\ 70\\-80\\%\\ specific\\ for\\ lung\\ metastasis\\,\\ and\\ it\\ is\\ negative\\ in\\ this\\ case\\.\\ \\ the\\ recurrent\\ breast\\ cancer\\ stage\\ is\\ t3n2m2\\ with\\ metastasis\\ to\\ the\\ liver\\ and\\ presumably\\ lung\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ breast\\:\\ 0\\.06626998680724885\ \(0\)\
\-\ liver\\:\\ 0\\.053085072267256284\ \(0\)\
\-\ ca\\:\\ 0\\.04182380723589361\ \(0\)\
\-\ \\:\\:\\ 0\\.03563929599970565\ \(0\)\
\-\ \\;\\:\\ 0\\.03041172955634525\ \(0\)\
\-\ lung\\:\\ 0\\.029731641083948903\ \(0\)\
\-\ ascites\\:\\ 0\\.029450422934164274\ \(0\)\
\-\ metastasis\\:\\ 0\\.02881754348017952\ \(0\)\
\-\ nodules\\:\\ 0\\.026595486977498133\ \(0\)\
\-\ t3n2m2\\:\\ 0\\.026473028300199694\ \(0\)\
\-\ histology\\:\\ 0\\.022873192818392476\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.02217149816554498\ \(0\)\
\-\ cancer\\:\\ 0\\.021089829312047788\ \(0\)\
\-\ cytokeratin\\:\\ 0\\.02062945427901257\ \(0\)\
\-\ bx\\:\\ 0\\.019874756296187023\ \(0\)\
\-\ hypermetabolic\\:\\ 0\\.019272141595099483\ \(0\)\
\-\ negative\\:\\ 0\\.01916006127158314\ \(0\)\
\-\ cea\\:\\ 0\\.018547931214267985\ \(0\)\
\-\ 125\\:\\ 0\\.01834074541400687\ \(0\)\
\-\ ductal\\:\\ 0\\.018144264329659696\ \(0\)\
\-\ \\,\\:\\ 0\\.01788474907321418\ \(0\)\
\-\ most\\:\\ 0\\.0177732895651178\ \(0\)\
\-\ stains\\:\\ 0\\.017476835286524044\ \(0\)\
\-\ lesions\\:\\ 0\\.017173877675254863\ \(0\)\
\-\ special\\:\\ 0\\.016688954612447494\ \(0\)\
\-\ recurrent\\:\\ 0\\.01624338860867152\ \(0\)\
\-\ lymph\\:\\ 0\\.01553847931957048\ \(0\)\
\-\ uptake\\:\\ 0\\.015292718129253207\ \(0\)\
\-\ cirrhosis\\:\\ 0\\.01510909546561032\ \(0\)\
\-\ pt\\:\\ 0\\.014311548444291678\ \(0\)\
\-\ 64\\:\\ 0\\.01398388991173221\ \(0\)\
\-\ infiltrating\\:\\ 0\\.013937330793005588\ \(0\)\
\-\ common\\:\\ 0\\.013431034306044427\ \(0\)\
\-\ chem7\\â\\€\\”141\\/5\\.0\\/105\\/31\\/12\\/0\\.6\\/112\\:\\ 0\\.013236514150099847\ \(0\)\
\-\ cbc\\â\\€\\”8\\.7\\/11\\.0\\/34\\.0\\/181\\:\\ 0\\.013236514150099847\ \(0\)\
\-\ coag\\:\\ 0\\.013236514150099847\ \(0\)\
\-\ 12\\.8\\/ptt\\:\\ 0\\.013236514150099847\ \(0\)\
\-\ lfts\\â\\€\\”alkphos\\:\\ 0\\.013236514150099847\ \(0\)\
\-\ 1052\\/ast\\:\\ 0\\.013236514150099847\ \(0\)\
\-\ 233\\/\\:\\ 0\\.013236514150099847\ \(0\)\
\-\ 91\\/\\:\\ 0\\.013236514150099847\ \(0\)\
\-\ 1371\\:\\ 0\\.013236514150099847\ \(0\)\
\-\ 1464\\:\\ 0\\.013236514150099847\ \(0\)\
\-\ 0\\-31\\:\\ 0\\.013236514150099847\ \(0\)\
\-\ progesterone\\/estrogen\\:\\ 0\\.013236514150099847\ \(0\)\
\-\ transcription\\:\\ 0\\.013236514150099847\ \(0\)\
\-\ scan\\â\\€\\”2\\:\\ 0\\.013236514150099847\ \(0\)\
\-\ diffuse\\/heterogeneous\\:\\ 0\\.013236514150099847\ \(0\)\
\-\ axial\\/appendicular\\:\\ 0\\.013236514150099847\ \(0\)\
\-\ mrcp\\/mri\\:\\ 0\\.013236514150099847\ \(0\)\
\-\ abdomen\\â\\€\\”liver\\:\\ 0\\.013236514150099847\ \(0\)\
\-\ chest\\â\\€\\”too\\:\\ 0\\.013236514150099847\ \(0\)\
\-\ bx\\â\\€\\”1\\.2cm\\:\\ 0\\.013236514150099847\ \(0\)\
\-\ nonsmokers\\:\\ 0\\.013236514150099847\ \(0\)\
\-\ ttf1\\:\\ 0\\.013236514150099847\ \(0\)\
\-\ workup\\:\\ 0\\.013203236685194896\ \(0\)\
\-\ type\\:\\ 0\\.01297578481237347\ \(0\)\
\-\ invasive\\:\\ 0\\.01289408362437675\ \(0\)\
\-\ hx\\:\\ 0\\.012704357193080858\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.012522689150638477\ \(0\)\
\-\ positive\\:\\ 0\\.012490475631910436\ \(0\)\
\-\ leading\\:\\ 0\\.012276668484246718\ \(0\)\
\-\ 15\\-3\\:\\ 0\\.012195752617727557\ \(0\)\
\-\ 196\\:\\ 0\\.012195752617727557\ \(0\)\
\-\ 0\\-34\\:\\ 0\\.012195752617727557\ \(0\)\
\-\ discharged\\:\\ 0\\.01176480067271948\ \(0\)\
\-\ nodes\\:\\ 0\\.011590664763859572\ \(0\)\
\-\ 27\\.8\\:\\ 0\\.011586946149096678\ \(0\)\
\-\ attend\\:\\ 0\\.011586946149096678\ \(0\)\
\-\ 27\\-29\\:\\ 0\\.011154991085355266\ \(0\)\
\-\ 0\\-37\\:\\ 0\\.011154991085355266\ \(0\)\
\-\ insisted\\:\\ 0\\.011154991085355266\ \(0\)\
\-\ for\\:\\ 0\\.010947569799440168\ \(0\)\
\-\ findings\\:\\ 0\\.010923945560300057\ \(0\)\
\-\ regenerating\\:\\ 0\\.010819940708006603\ \(0\)\
\-\ 19\\-9\\:\\ 0\\.010819940708006603\ \(0\)\
\-\ include\\:\\ 0\\.010797988684821111\ \(0\)\
\-\ panels\\:\\ 0\\.010546184616724389\ \(0\)\
\-\ 70\\-80\\:\\ 0\\.010546184616724389\ \(0\)\
\-\ lobe\\:\\ 0\\.010357321387042945\ \(0\)\
\-\ pulmonology\\:\\ 0\\.010314727139506284\ \(0\)\
\-\ birads\\:\\ 0\\.010314727139506284\ \(0\)\
\-\ periportal\\:\\ 0\\.010314727139506284\ \(0\)\
\-\ appointments\\:\\ 0\\.010114229552982976\ \(0\)\
\-\ medpix\\:\\ 0\\.010114229552982976\ \(0\)\
\-\ 15\\-20\\:\\ 0\\.009779179175634313\ \(0\)\
\-\ lungs\\:\\ 0\\.009717082876817645\ \(0\)\
\-\ non\\-calcified\\:\\ 0\\.009636070797549742\ \(0\)\
\-\ in\\:\\ 0\\.009490928606762499\ \(0\)\
\-\ malignant\\:\\ 0\\.009275287316454358\ \(0\)\
\-\ aforementioned\\:\\ 0\\.009273965607133993\ \(0\)\
\-\ interstitium\\:\\ 0\\.009273965607133993\ \(0\)\
\-\ u\\/s\\:\\ 0\\.009073468020610686\ \(0\)\
\-\ wf\\:\\ 0\\.008982440059925349\ \(0\)\
\-\ lb\\:\\ 0\\.008982440059925349\ \(0\)\
\-\ girth\\:\\ 0\\.008982440059925349\ \(0\)\
\-\ sex\\:\\ 0\\.008982440059925349\ \(0\)\
\-\ mycobacterial\\:\\ 0\\.008896616615721222\ \(0\)\
\-\ capsular\\:\\ 0\\.008815434601801888\ \(0\)\
\-\ 3\\.\\:\\ 0\\.008780403039461643\ \(0\)\
\-\ splenomegaly\\:\\ 0\\.008738417643262022\ \(0\)\
\-\ xrt\\:\\ 0\\.008738417643262022\ \(0\)\
\-\ accounting\\:\\ 0\\.008738417643262022\ \(0\)\
\-\ elevated\\:\\ 0\\.008706655739817005\ \(0\)\
\-\ \\(\\:\\ 0\\.008677017732658986\ \(0\)\
\-\ tbili\\:\\ 0\\.008665159138503116\ \(0\)\
\-\ focally\\:\\ 0\\.00859530926517745\ \(0\)\
\-\ presumably\\:\\ 0\\.00859530926517745\ \(0\)\
\-\ \\)\\:\\ 0\\.00857102332868835\ \(0\)\
\-\ 2\\.7\\:\\ 0\\.008528564876932956\ \(0\)\
\-\ markers\\:\\ 0\\.008528564876932956\ \(0\)\
\-\ hcc\\:\\ 0\\.008464661551979807\ \(0\)\
\-\ lumpectomy\\:\\ 0\\.008464661551979807\ \(0\)\
\-\ lfts\\:\\ 0\\.008464661551979807\ \(0\)\
\-\ is\\:\\ 0\\.008442804480251136\ \(0\)\
\-\ took\\:\\ 0\\.00840336726591336\ \(0\)\
\-\ category\\:\\ 0\\.00840336726591336\ \(0\)\
\-\ organomegaly\\:\\ 0\\.00818051440537541\ \(0\)\
\-\ 2\\.\\:\\ 0\\.008160492918319093\ \(0\)\
\-\ retraction\\:\\ 0\\.008129611174631145\ \(0\)\
\-\ histologic\\:\\ 0\\.008129611174631145\ \(0\)\
\-\ pack\\:\\ 0\\.008129611174631145\ \(0\)\
\-\ normal\\:\\ 0\\.008045720448042649\ \(0\)\
\-\ 1996\\:\\ 0\\.008032706488238395\ \(0\)\
\-\ image\\:\\ 0\\.008015583081974777\ \(0\)\
\-\ 1\\.\\:\\ 0\\.008015583081974777\ \(0\)\
\-\ afp\\:\\ 0\\.00789815369741304\ \(0\)\
\-\ stain\\:\\ 0\\.00789815369741304\ \(0\)\
\-\ plan\\:\\ 0\\.007855855083348932\ \(0\)\
\-\ skeleton\\:\\ 0\\.007855855083348932\ \(0\)\
\-\ lesion\\:\\ 0\\.007840338855857904\ \(0\)\
\-\ age\\:\\ 0\\.0078105415181510705\ \(0\)\
\-\ consult\\:\\ 0\\.007624397606130825\ \(0\)\
\-\ indicates\\:\\ 0\\.00755454773280516\ \(0\)\
\-\ colonoscopy\\:\\ 0\\.007487803344560665\ \(0\)\
\-\ y\\.o\\:\\ 0\\.007406544842602703\ \(0\)\
\-\ hepatitis\\:\\ 0\\.0073626057335410685\ \(0\)\
\-\ work\\-up\\:\\ 0\\.007247048614718054\ \(0\)\
\-\ pertinent\\:\\ 0\\.007219497355456497\ \(0\)\
\-\ she\\:\\ 0\\.007203561986348865\ \(0\)\
\-\ left\\:\\ 0\\.0071779674870338945\ \(0\)\
\-\ core\\:\\ 0\\.007114085555646815\ \(0\)\
\-\ event\\:\\ 0\\.007088849642258856\ \(0\)\
\-\ htn\\:\\ 0\\.007064030870560341\ \(0\)\
\-\ months\\:\\ 0\\.007008832716786989\ \(0\)\
\-\ infiltration\\:\\ 0\\.006991944955866105\ \(0\)\
\-\ percent\\:\\ 0\\.006991944955866105\ \(0\)\
\-\ alt\\:\\ 0\\.006968665396502794\ \(0\)\
\-\ axillary\\:\\ 0\\.006968665396502794\ \(0\)\
\-\ final\\:\\ 0\\.0069231618687320305\ \(0\)\
\-\ assessment\\:\\ 0\\.006900916995180768\ \(0\)\
\-\ fatigue\\:\\ 0\\.006857392165040749\ \(0\)\
\-\ gestational\\:\\ 0\\.0068360939143020764\ \(0\)\
\-\ outer\\:\\ 0\\.006815093550976641\ \(0\)\
\-\ non\\-tender\\:\\ 0\\.0067943828570842454\ \(0\)\
\-\ detected\\:\\ 0\\.0067739539500935855\ \(0\)\
\-\ portal\\:\\ 0\\.006753799264910192\ \(0\)\
\-\ pet\\:\\ 0\\.006733911537057308\ \(0\)\
\-\ peritoneal\\:\\ 0\\.0066757816388881034\ \(0\)\
\-\ that\\:\\ 0\\.00664856184035506\ \(0\)\
\-\ nonspecific\\:\\ 0\\.006601618342597448\ \(0\)\
\-\ neoplastic\\:\\ 0\\.006565866617832104\ \(0\)\
\-\ factor\\:\\ 0\\.0065483049965660515\ \(0\)\
\-\ setting\\:\\ 0\\.006480043173627978\ \(0\)\
\-\ smoking\\:\\ 0\\.006480043173627978\ \(0\)\
\-\ viral\\:\\ 0\\.006463451828002475\ \(0\)\
\-\ adult\\:\\ 0\\.006430809205425288\ \(0\)\
\-\ frequent\\:\\ 0\\.006414750212757499\ \(0\)\
\-\ thus\\:\\ 0\\.006383138487235229\ \(0\)\
\-\ series\\:\\ 0\\.006383138487235229\ \(0\)\
\-\ six\\:\\ 0\\.0063069037644523105\ \(0\)\
\-\ physical\\:\\ 0\\.006295811620364079\ \(0\)\
\-\ consistent\\:\\ 0\\.006292186993487096\ \(0\)\
\-\ lab\\:\\ 0\\.006277461615220514\ \(0\)\
\-\ pancreatic\\:\\ 0\\.006277461615220514\ \(0\)\
\-\ place\\:\\ 0\\.0062343533481297765\ \(0\)\
\-\ women\\:\\ 0\\.0062343533481297765\ \(0\)\
\-\ distended\\:\\ 0\\.0062062870823457635\ \(0\)\
\-\ spread\\:\\ 0\\.0062062870823457635\ \(0\)\
\-\ granulomatous\\:\\ 0\\.006192448260866899\ \(0\)\
\-\ tb\\:\\ 0\\.006178735823084207\ \(0\)\
\-\ 70\\:\\ 0\\.006165147481462709\ \(0\)\
\-\ tissue\\:\\ 0\\.00608234591126905\ \(0\)\
\-\ 80\\:\\ 0\\.006035627444999635\ \(0\)\
\-\ imaging\\:\\ 0\\.006012233707073882\ \(0\)\
\-\ discussion\\:\\ 0\\.006011012115006127\ \(0\)\
\-\ recently\\:\\ 0\\.005986793823820116\ \(0\)\
\-\ \\-\\-\\:\\ 0\\.0058936475912083255\ \(0\)\
\-\ diagnosis\\:\\ 0\\.005892550542884144\ \(0\)\
\-\ node\\:\\ 0\\.0058712367049971\ \(0\)\
\-\ this\\:\\ 0\\.005772595875760559\ \(0\)\
\-\ to\\:\\ 0\\.005771190654634949\ \(0\)\
\-\ important\\:\\ 0\\.005763940963282168\ \(0\)\
\-\ numerous\\:\\ 0\\.005753621324711955\ \(0\)\
\-\ report\\:\\ 0\\.005743372127909552\ \(0\)\
\-\ fibrosis\\:\\ 0\\.005713037732537902\ \(0\)\
\-\ exam\\:\\ 0\\.005637339159007622\ \(0\)\
\-\ case\\:\\ 0\\.00561412742602784\ \(0\)\
\-\ either\\:\\ 0\\.0055882405753149185\ \(0\)\
\-\ count\\:\\ 0\\.005579057051264714\ \(0\)\
\-\ have\\:\\ 0\\.005556871106201477\ \(0\)\
\-\ admitted\\:\\ 0\\.005542874541386245\ \(0\)\
\-\ infectious\\:\\ 0\\.005516298599795553\ \(0\)\
\-\ foci\\:\\ 0\\.005507543464193762\ \(0\)\
\-\ dilatation\\:\\ 0\\.005498839083286365\ \(0\)\
\-\ stage\\:\\ 0\\.00547302466806058\ \(0\)\
\-\ inflammation\\:\\ 0\\.0054560583688805005\ \(0\)\
\-\ function\\:\\ 0\\.005439281641255687\ \(0\)\
\-\ site\\:\\ 0\\.005422690295630184\ \(0\)\
\-\ general\\:\\ 0\\.005406280279816085\ \(0\)\
\-\ 40\\:\\ 0\\.005398142040372633\ \(0\)\
\-\ s\\/p\\:\\ 0\\.005381996707375243\ \(0\)\
\-\ mass\\:\\ 0\\.005353427959223263\ \(0\)\
\-\ references\\:\\ 0\\.005334576929521941\ \(0\)\
\-\ after\\:\\ 0\\.005309312920748356\ \(0\)\
\-\ specific\\:\\ 0\\.005303775818661426\ \(0\)\
\-\ thyroid\\:\\ 0\\.005258727394781848\ \(0\)\
\-\ family\\:\\ 0\\.005258727394781848\ \(0\)\
\-\ pathology\\:\\ 0\\.0052513489941776\ \(0\)\
\-\ placed\\:\\ 0\\.005193591815757486\ \(0\)\
\-\ cells\\:\\ 0\\.005144814856081077\ \(0\)\
\-\ made\\:\\ 0\\.005110919477644832\ \(0\)\
\-\ diagnostic\\:\\ 0\\.00508434353605414\ \(0\)\
\-\ also\\:\\ 0\\.005058917698709163\ \(0\)\
\-\ vs\\:\\ 0\\.005051771727328525\ \(0\)\
\-\ 4\\.\\:\\ 0\\.005051771727328525\ \(0\)\
\-\ failure\\:\\ 0\\.005026213637884935\ \(0\)\
\-\ reveals\\:\\ 0\\.005019891516959495\ \(0\)\
\-\ second\\:\\ 0\\.004928121524382849\ \(0\)\
\-\ used\\:\\ 0\\.0049221984338557985\ \(0\)\
\-\ 7\\:\\ 0\\.004916298616828937\ \(0\)\
\-\ and\\:\\ 0\\.004865108263032931\ \(0\)\
\-\ hospital\\:\\ 0\\.004830475172624809\ \(0\)\
\-\ has\\:\\ 0\\.0048189188303131465\ \(0\)\
\-\ 8\\:\\ 0\\.0047974738111852076\ \(0\)\
\-\ studies\\:\\ 0\\.0047920434200888285\ \(0\)\
\-\ which\\:\\ 0\\.00479022398571336\ \(0\)\
\-\ laboratory\\:\\ 0\\.00472836596975085\ \(0\)\
\-\ reported\\:\\ 0\\.004677289565429147\ \(0\)\
\-\ peripheral\\:\\ 0\\.004642542525546723\ \(0\)\
\-\ 20\\:\\ 0\\.004613386240476\ \(0\)\
\-\ otherwise\\:\\ 0\\.004608581431571088\ \(0\)\
\-\ weight\\:\\ 0\\.004599017695406705\ \(0\)\
\-\ biopsy\\:\\ 0\\.00455209195440955\ \(0\)\
\-\ being\\:\\ 0\\.004471153118319157\ \(0\)\
\-\ benign\\:\\ 0\\.004428003554103906\ \(0\)\
\-\ neoplasm\\:\\ 0\\.004369604468336228\ \(0\)\
\-\ inferior\\:\\ 0\\.004353327869908503\ \(0\)\
\-\ masses\\:\\ 0\\.0043372258228169475\ \(0\)\
\-\ available\\:\\ 0\\.004313391965224921\ \(0\)\
\-\ day\\:\\ 0\\.004073513257286681\ \(0\)\
\-\ differential\\:\\ 0\\.004073513257286681\ \(0\)\
\-\ show\\:\\ 0\\.003938672574311751\ \(0\)\
\-\ days\\:\\ 0\\.0039325439882462124\ \(0\)\
\-\ diffuse\\:\\ 0\\.0038843955260890613\ \(0\)\
\-\ patient\\:\\ 0\\.003858522211335081\ \(0\)\
\-\ abdomen\\:\\ 0\\.00380087727161516\ \(0\)\
\-\ primary\\:\\ 0\\.00380087727161516\ \(0\)\
\-\ demonstrated\\:\\ 0\\.003764894868554005\ \(0\)\
\-\ 5\\:\\ 0\\.0037539946282945397\ \(0\)\
\-\ the\\:\\ 0\\.0037364671541520486\ \(0\)\
\-\ evaluation\\:\\ 0\\.0037270852790192307\ \(0\)\
\-\ loss\\:\\ 0\\.0037244206793820415\ \(0\)\
\-\ focal\\:\\ 0\\.0036644048110186216\ \(0\)\
\-\ fluid\\:\\ 0\\.0036466052621679478\ \(0\)\
\-\ weeks\\:\\ 0\\.0036415581935452675\ \(0\)\
\-\ carcinoma\\:\\ 0\\.0036365280330568567\ \(0\)\
\-\ likely\\:\\ 0\\.003619054002906391\ \(0\)\
\-\ an\\:\\ 0\\.0035485431359901795\ \(0\)\
\-\ are\\:\\ 0\\.003498119737326131\ \(0\)\
\-\ these\\:\\ 0\\.003339106144080841\ \(0\)\
\-\ prior\\:\\ 0\\.0032944636219254704\ \(0\)\
\-\ metastatic\\:\\ 0\\.003229893999423559\ \(0\)\
\-\ abdominal\\:\\ 0\\.003207085943126299\ \(0\)\
\-\ bone\\:\\ 0\\.003188340362552357\ \(0\)\
\-\ increased\\:\\ 0\\.0031388660387382215\ \(0\)\
\-\ surgery\\:\\ 0\\.0031156142107511635\ \(0\)\
\-\ upper\\:\\ 0\\.0030962169750281057\ \(0\)\
\-\ 1\\:\\ 0\\.0030530425945340944\ \(0\)\
\-\ \\%\\:\\ 0\\.002992974524543555\ \(0\)\
\-\ tumor\\:\\ 0\\.002991339792208425\ \(0\)\
\-\ can\\:\\ 0\\.0029102437724760804\ \(0\)\
\-\ present\\:\\ 0\\.0028979110419394606\ \(0\)\
\-\ it\\:\\ 0\\.002884156733533058\ \(0\)\
\-\ right\\:\\ 0\\.0027076027300613112\ \(0\)\
\-\ multiple\\:\\ 0\\.002702411416635539\ \(0\)\
\-\ female\\:\\ 0\\.0026377781853571076\ \(0\)\
\-\ treatment\\:\\ 0\\.0025970224618631936\ \(0\)\
\-\ no\\:\\ 0\\.002583916368479886\ \(0\)\
\-\ with\\:\\ 0\\.0022838652990519017\ \(0\)\
\-\ of\\:\\ 0\\.002274098213774549\ \(0\)\
\-\ be\\:\\ 0\\.0019786136987146085\ \(0\)\
\-\ not\\:\\ 0\\.0018540820897026058\ \(0\)\
\-\ ct\\:\\ 0\\.0017947502303183828\ \(0\)\
\-\ history\\:\\ 0\\.001772093900461086\ \(0\)\
\-\ or\\:\\ 0\\.0015037879113569182\ \(0\)\
\-\ was\\:\\ 0\\.0014839001835040343\ \(0\)\
\-\ year\\:\\ 0\\.001435593497406779\ \(0\)\
\-\ \\.\\:\\ 0\\.0012259599553137602\ \(0\)\
\-\ on\\:\\ 0\\.0010869234419901323\ \(0\)\
\-\ a\\:\\ 0\\.0005954951979258278\ \(0\)\
